Evidence map›Paper›PMID 38439921›Full record

ArticleFrontiers in nutrition2024

A novel IgE epitope-specific antibodies-based sandwich ELISA for sensitive measurement of immunoreactivity changes of peanut allergen Ara h 2 in processed foods.

Yan Yan, Liming Li, Caiyun Long, Yaping Dong, Jinyu Li, Caiyi Shen, Yiqian Zhao, Jiangqiang Zhao, Jianbin Wang, Anqi Xiong and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in nutrition, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 5 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Yan YanSchool of Public Health and Health Management, Gannan Medical University, Ganzhou, China.
Liming LiDepartment of Dermatology, First Affiliated Hospital of Gannan Medical University, Ganzhou, China.
Caiyun LongDepartment of Laboratory, Ganzhou Center for Disease Control and Prevention, Ganzhou, China.
Yaping DongSchool of Public Health and Health Management, Gannan Medical University, Ganzhou, China.
Jinyu LiDepartment of Dermatology, First Affiliated Hospital of Gannan Medical University, Ganzhou, China.
Caiyi ShenSchool of Public Health and Health Management, Gannan Medical University, Ganzhou, China.
Yiqian ZhaoSchool of Public Health and Health Management, Gannan Medical University, Ganzhou, China.
Jiangqiang ZhaoSchool of Public Health and Health Management, Gannan Medical University, Ganzhou, China.
Jianbin WangSchool of Public Health and Health Management, Gannan Medical University, Ganzhou, China.
Anqi XiongSchool of Public Health and Health Management, Gannan Medical University, Ganzhou, China.
Xin LiState Key Laboratory of Food Science and Resources, Nanchang University, Nanchang, China.
Hongbing ChenState Key Laboratory of Food Science and Resources, Nanchang University, Nanchang, China.
Shengfa HeSchool of Public Health and Health Management, Gannan Medical University, Ganzhou, China.
Gannan Medical University · CNFirst Affiliated Hospital of Gannan Medical University · CNState Key Laboratory of Food Science and Technology · CNGansu Provincial Center for Disease Control and Prevention · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Peanut is an important source of dietary protein for human beings, but it is also recognized as one of the eight major food allergens. Binding of IgE antibodies to specific epitopes in peanut allergens plays important roles in initiating peanut-allergic reactions, and Ara h 2 is widely considered as the most potent peanut allergen and the best predictor of peanut allergy. Therefore, Ara h 2 IgE epitopes can serve as useful biomarkers for prediction of IgE-binding variations of Ara h 2 and peanut in foods. This study aimed to develop and validate an IgE epitope-specific antibodies (IgE-EsAbs)-based sandwich ELISA (sELISA) for detection of Ara h 2 and measurement of Ara h 2 IgE-immunoreactivity changes in foods. Methods: DEAE-Sepharose Fast Flow anion-exchange chromatography combining with SDS-PAGE gel extraction were applied to purify Ara h 2 from raw peanut. Hybridoma and epitope vaccine techniques were employed to generate a monoclonal antibody against a major IgE epitope of Ara h 2 and a polyclonal antibody against 12 IgE epitopes of Ara h 2, respectively. ELISA was carried out to evaluate the target binding and specificity of the generated IgE-EsAbs. Subsequently, IgE-EsAbs-based sELISA was developed to detect Ara h 2 and its allergenic residues in food samples. The IgE-binding capacity of Ara h 2 and peanut in foods was determined by competitive ELISA. The dose-effect relationship between the Ara h 2 IgE epitope content and Ara h 2 (or peanut) IgE-binding ability was further established to validate the reliability of the developed sELISA in measuring IgE-binding variations of Ara h 2 and peanut in foods. Results: The obtained Ara h 2 had a purity of 94.44%. Antibody characterization revealed that the IgE-EsAbs recognized the target IgE epitope(s) of Ara h 2 and exhibited high specificity. Accordingly, an IgE-EsAbs-based sELISA using these antibodies was able to detect Ara h 2 and its allergenic residues in food samples, with high sensitivity (a limit of detection of 0.98 ng/mL), accuracy (a mean bias of 0.88%), precision (relative standard deviation < 16.50%), specificity, and recovery (an average recovery of 98.28%). Moreover, the developed sELISA could predict IgE-binding variations of Ara h 2 and peanut in foods, as verified by using sera IgE derived from peanut-allergic individuals. Conclusion: This novel immunoassay could be a user-friendly method to monitor low level of Ara h 2 and to preliminary predict

Indexed as

Ara h 2IgE-bindingIgE epitope-specific antibodiespeanut allergensandwich ELISA

Identifiers

PMID38439921
PMCPMC10910080
OpenAlexW4391928931

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.